Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy - Université de Lorraine
Journal Articles Clinical Gastroenterology and Hepatology Year : 2019

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

Domains

Life Sciences [q-bio] Human health and pathology Hépatology and Gastroenterology Rhumatology and musculoskeletal system

Philippe DE CARVALHO  : Connect in order to contact the contributor

https://hal.univ-lorraine.fr/hal-02549581

Submitted on : Tuesday, April 21, 2020-3:54:20 PM

Last modification on : Monday, April 15, 2024-6:10:03 PM

Consult the full text

Dates and versions

hal-02549581 , version 1 (21-04-2020)

Identifiers

Cite

Catherine Le Berre, Damien Loeuille, Laurent Peyrin-Biroulet. Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy. Clinical Gastroenterology and Hepatology, 2019, 17 (4), pp.794-796. ⟨10.1016/j.cgh.2018.08.017⟩. ⟨hal-02549581⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-NANTES CNRS UNIV-LORRAINE NGERE-UL IMPACT-GEENAGE BMS-UL IMOPA-EQ5 IMOPA-CLN NANTES-UNIVERSITE
61 View
0 Download

Altmetric

Share

More